308 related articles for article (PubMed ID: 28756472)
1. Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer.
Voog E; Campion L; du Rusquec P; Bourgeois H; Domont J; Denis F; Emmanuel E; Dupuis O; Ganem G; Lafont C; Le Du K; Pavluc E; Pointreau Y; Roche S; Juhel-Voog L; Zinger M; Solal-Celigny P
Support Care Cancer; 2018 Jan; 26(1):81-89. PubMed ID: 28756472
[TBL] [Abstract][Full Text] [Related]
2. Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J
Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073
[TBL] [Abstract][Full Text] [Related]
3. Does the Implantation Technique for Totally Implantable Venous Access Ports (TIVAPs) Influence Long-Term Outcome?
Biacchi D; Sammartino P; Sibio S; Accarpio F; Cardi M; Sapienza P; De Cesare A; Atta JM; Impagnatiello A; Di Giorgio A
World J Surg; 2016 Feb; 40(2):284-90. PubMed ID: 26341511
[TBL] [Abstract][Full Text] [Related]
4. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
[TBL] [Abstract][Full Text] [Related]
5. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
[TBL] [Abstract][Full Text] [Related]
6. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcomes of the single-incision technique for implantation of implantable venous access ports via the axillary vein.
Seo TS; Song MG; Kim JS; Choi CW; Seo JH; Oh SC; Kang EJ; Lee JK; Lee SY
J Vasc Access; 2017 Jul; 18(4):345-351. PubMed ID: 28665466
[TBL] [Abstract][Full Text] [Related]
8. Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports-a complication analysis of more than 1000 TIVAP implantations.
Thiel K; Kalmbach S; Maier G; Wichmann D; Schenk M; Königsrainer A; Thiel C
Langenbecks Arch Surg; 2022 Dec; 407(8):3755-3762. PubMed ID: 36070032
[TBL] [Abstract][Full Text] [Related]
9. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections.
Kaya E; Tollapi L; Pastore A; Aringhieri G; Maisetta G; Barnini S; Paolicchi A; Batoni G; Esin S
J Med Microbiol; 2020 Nov; 69(11):1273-1284. PubMed ID: 33064069
[No Abstract] [Full Text] [Related]
11. Incidence and risk factor for infection of totally implantable venous access port.
Chang TC; Yen MH; Kiu KT
Langenbecks Arch Surg; 2022 Feb; 407(1):343-351. PubMed ID: 34550464
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of ultrasound-guided totally implantable venous access ports via the right innominate vein in adult patients with cancer: Single-centre experience and protocol.
Sun X; Xu J; Xia R; Wang C; Yu Z; Zhang J; Bai X; Jin Y
Eur J Surg Oncol; 2019 Feb; 45(2):275-278. PubMed ID: 30087070
[TBL] [Abstract][Full Text] [Related]
13. Late complications of totally implantable venous access ports in patients with cancer: Risk factors and related nursing strategies.
Yu XY; Xu JL; Li D; Jiang ZF
Medicine (Baltimore); 2018 Sep; 97(38):e12427. PubMed ID: 30235721
[TBL] [Abstract][Full Text] [Related]
14. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
15. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
Narducci F; Jean-Laurent M; Boulanger L; El Bédoui S; Mallet Y; Houpeau JL; Hamdani A; Penel N; Fournier C
Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
[TBL] [Abstract][Full Text] [Related]
16. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.
Xu H; Chen R; Jiang C; You S; Zhu Q; Li Y; Li S; Zha X; Wang J
J Vasc Access; 2020 Sep; 21(5):609-614. PubMed ID: 31841061
[TBL] [Abstract][Full Text] [Related]
17. A Comparison Between Upper Arm and Chest for Optimal Site of Totally Implanted Venous Access Ports in Patients with Female Breast Cancer.
Yang SS; Ahn MS
Ann Vasc Surg; 2018 Jul; 50():128-134. PubMed ID: 29481918
[TBL] [Abstract][Full Text] [Related]
18. Safety of immediate use of totally implantable venous access ports in adult patients with cancer: a retrospective single-center study.
Lee J; Hur SM; Kim Z; Lim CW
Korean J Clin Oncol; 2021 Dec; 17(2):104-110. PubMed ID: 36945672
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
[TBL] [Abstract][Full Text] [Related]
20. Implanting totally implantable venous access port via the internal jugular vein guided by ultrasonography is feasible and safe in patients with breast cancer.
Zhou J; Qian S; He W; Han G; Li H; Luo R
World J Surg Oncol; 2014 Dec; 12():378. PubMed ID: 25487539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
